BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IDP-001 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of IDP-001\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07602842-2537@assetmemo.bio
DTSTAMP:20261121T005644Z
DTSTART;VALUE=DATE:20280630
DTEND;VALUE=DATE:20280701
SUMMARY:IDP-001: Phase 1/2 readout est. (NCT07602842)
DESCRIPTION:IDP-001\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy: A Stu
 dy of IDP-001 in Advanced or Metastatic Solid Tumors\nEstimated primary co
 mpletion: June 2028. This is a ClinicalTrials.gov estimate\, not a confirm
 ed readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/
 idp-001#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07602842
URL:https://assetmemo.bio/drug/idp-001#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
